Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: Comparison of other ethnic groups

European Journal of Clinical Pharmacology

Volumn 61, Issue 10, 2005, Pages 743-747

  Kim, Kyoung Ah ^a   Lee, Sook Young ^a   Park, Pil Whan ^a   Ha, Jong Myung ^b   Park, Ji Young ^a  

^a Gachon University College of Medicine   (South Korea)

^b Silla University   (South Korea)

Author keywords

Genetic polymorphism; Linkage disequilibrium; Sulfotransferase; SULT1A1; SULT1A2

Indexed keywords

SULFOTRANSFERASE;

ARTICLE; ASIAN; CAUCASIAN; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPAN; KOREA; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ARYLSULFOTRANSFERASE; BASE SEQUENCE; CHROMOSOME MAPPING; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 27944443262     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0989-3     Document Type: Article

References (30)

1. Otterness DM, Weinshilboum R (1994) Human dehydroepiandrosterone sulfotransferase: molecular cloning of cDNA and genomic DNA. Chem Biol Interact 92:145-159
2. Falany CN (1997) Enzymology of human cytosolic sulfotransferases. FASEB J 11:206-216
3. Nebert DW (1997) Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 60:265-271
4. Bamber DE, Fryer AA, Strange RC, Elder JB, Deakin M, Rajagopal R, Fawole A, Gilissen RAHJ, Campbell FC, Coughtrie MWH (2001) Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11:679-685
5. Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA, Polyak K (2000) Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 60:6859-6863
6. Nowell S, Sweeney C, Winters M, Stone A, Lang NP, Hutchins LF, Kadlubar FF, Ambrosone CB (2002) Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst 94:1635-1640
7. Wilborn TW, Comer KA, Dooley TP, Reardon IM, Heinrikson RL, Falany CN (1993) Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol Pharmacol 43:70-77
8. Zhu X, Veronese ME, Sansom LN, McManus ME (1993) Molecular characterisation of a human aryl sulfotransferase cDNA. Biochem Biophys Res Commun 192:671-676
9. Ozawa S, Nagata K, Shimada M, Ueda M, Tsuzuki T, Yamazoe Y, Kato R (1995) Primary structures and properties of two related forms of aryl sulfotransferases in human liver. Pharmacogenetics 5:S135-S140
10. Hart RF, Renskers KJ, Nelson EB, Roth JA (1979) Localization and characterization of phenol sulfotransferase in human platelets. Life Sci 24:125-130
11. Rein G, Glover V, Sandler M (1982) Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenol. Biochem Pharmacol 31:1893-1897
12. Young WF Jr, Okazaki H, Laws ER Jr, Weinshilboum RM (1984) Human brain phenol sulfotransferase: biochemical properties and regional localization. J Neurochem 43:706-715
13. Coughtrie MWH, Gilissen RAHJ, Shek B, Strange RC, Fryer AA, Jones PW, Bamber DE (1999) Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 337:45-49
14. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM (1997) Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239:298-304
15. Raftogianis RB, Wood TC, Weinshilboum RM (1999) Human phenol sulfotransferases SULT1A2 and SULT1A1. Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 58:605-616
16. Zhu X, Veronese ME, Iocco P, McManus ME (1996) cDNA cloning and expression of a new form of human aryl sulfotransferase. Int J Biochem Cell Biol 28:565-571
17. Meinl W, Meerman JH, Glatt H (2002) Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium. Pharmacogenetics 12:677-689
18. Engelke CEH, Meinl W, Boeing H, Glatt H (2000) Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. Pharmacogenetics 10:163-169
19. Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM (2001) Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 11:57-68
20. Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF, Lee TP, Shih MC, Chang JY, Chang JG (2003) The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med 11:85-89
21. Terwilliger JD, Ott J (1993) A novel polylocus method for linkage analysis using the lod-score or affected sib-pair method. Genet Epidemiol 10:477-482
22. Falconer DS, Mackay TFC (1989) Introduction to quantitative genetics, 4th edn. Longman Group, Harlow
23. Hartl DL, Clark AG (1989) Principles of population genetics, 2nd edn. Sinauer Associates, Sunderland, MA
24. Nagata K, Yamazoe Y(2000) Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol 40:159-176
25. Raftogianis RB, Her C, Weinshilboum RM (1996) Human phenol sulfotransferase pharmacogenetics: STP1 gene cloning and structural characterization. Pharmacogenetics 6:473-487
26. Honma W, Kamiyama Y, Yoshinari K, Sasano H, Shimada M, Nagata K, Yamazoe Y (2001) Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms. Drug Metab Dispos 29:274-281
27. Wang Y, Spitz MR, Tsou AM, Zhang K, Makan N, Wu X (2002) Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer 35:137-142
28. Levy RH, Thummel KE, Trager WF, Hanstein PD, Eichelbaum M (2000) Sulfotransferase and methyltransferase. In: Metabolic drug interactions, 1st edn. Lippincott Williams & Wilkins, Philadelphia, pp 191-204
29. Kauffman FC (2004) Sulfonation in pharmacology and toxicology. Drug Metab Rev 36:823-843
30. Rossi AM, Maggini V, Fredianelli E, Di Bello D, Pietrabissa A, Mosca F, Barale R, Pacifici GM (2004) Phenotype-genotype relationships of SULT1A1 in human liver and variations in the IC50 of the SULT1A1 inhibitor quercetin. Int J Clin Pharmacol Ther 42:561-567